Ignite Creation Date:
2024-05-06 @ 8:05 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06246916
Status:
RECRUITING
Last Update Posted:
2024-05-01
First Post:
2024-01-30
Brief Title:
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma
Sponsor:
Organization:
Regeneron Pharmaceuticals